Bolt Biotherapeutics, Inc. (BOLT)

NASDAQ: BOLT · Real-Time Price · USD

0.3764

-0.0126 (-3.24%)

Apr 25, 2025, 12:00 PM EDT - Market open

Bolt Biotherapeutics Employees

Bolt Biotherapeutics had 52 employees as of December 31, 2024. The number of employees decreased by 48 or -48.00% compared to the previous year.

Employees

52

Change (1Y)

-48

Growth (1Y)

-48.00%

Revenue / Employee

$147,885

Profits / Employee

-$1,213,808

Market Cap

14.43M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	52	-48	-48.00%
Dec 31, 2023	100	6	6.38%
Dec 31, 2022	94	3	3.30%
Dec 31, 2021	91	26	40.00%
Dec 31, 2020	65	-	-

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novartis AG	75,883

Employee Rankings

BOLT News

4 weeks ago - Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025 - GlobeNewsWire
4 weeks ago - Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update - GlobeNewsWire
2 months ago - Bolt Biotherapeutics to Participate in Upcoming March Conferences - GlobeNewsWire
2 months ago - Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc. - GlobeNewsWire
6 months ago - Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting - GlobeNewsWire
8 months ago - Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm - Accesswire
8 months ago - Bolt Biotherapeutics Announces Changes to its Board of Directors - GlobeNewsWire
8 months ago - Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm - Accesswire